7105 Phase II trial of the oral multikinase inhibitor BAY 73–4506 as 1st-line therapy in patients with metastatic or unresectable renal cell cancer (RCC)
暂无分享，去创建一个
T. Eisen | H. Joensuu | P. Nathan | D. Quinn | P. Tomczak | M. Wojtukiewicz | S. Nicholson | P. Harper | A. Bahl | A. Wagner